Cargando…
Low circadian clock genes expression in cancers: A meta-analysis of its association with clinicopathological features and prognosis
BACKGROUND: Per1, Per2, Per3, Cry1, Cry2, Bmal1, Npas2 and CLOCK genes are the eight core circadian clock genes. Low expression of these circadian clock genes plays an important role in the progression of cancers. However, its clinicopathological and prognostic value in patients with cancers remains...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241715/ https://www.ncbi.nlm.nih.gov/pubmed/32437452 http://dx.doi.org/10.1371/journal.pone.0233508 |
_version_ | 1783537112574853120 |
---|---|
author | Zhang, Jiangguo Lv, Hong Ji, Mingzhu Wang, Zhimo Wu, Wenqing |
author_facet | Zhang, Jiangguo Lv, Hong Ji, Mingzhu Wang, Zhimo Wu, Wenqing |
author_sort | Zhang, Jiangguo |
collection | PubMed |
description | BACKGROUND: Per1, Per2, Per3, Cry1, Cry2, Bmal1, Npas2 and CLOCK genes are the eight core circadian clock genes. Low expression of these circadian clock genes plays an important role in the progression of cancers. However, its clinicopathological and prognostic value in patients with cancers remains controversial and inconclusive. We performed a meta-analysis of studies assessing the clinicopathological and prognostic significance of low expression of these genes in cancers. METHODS: Relevant studies were searched from the Cochrane Central Register of Controlled Trials, Embase, EBSCO, Ovid, PubMed, Science Direct, Wiley Online Library database, CNKI and Wan Fang database. The meta-analysis was performed by using STATA version 12 software. A random-effect model was employed to evaluate all pooled hazard ratios (HRs) and odd ratios (ORs). RESULTS: A total of 36 studies comprising 7476 cases met the inclusion criteria. Meta-analysis suggested that low expression of Per1 was associated with poor differentiation (Per1: OR=2.30, 95%CI: 1.36∼3.87, P=0.002) and deeper invasion depth (Per1: OR=2.12, 95%CI: 1.62∼2.77, Ρ<0.001); low Per2 expression was correlated with poor differentiation (Per2: OR=2.41, 95%CI: 1.53∼3.79, Ρ<0.001), worse TNM stage (Per2:OR=3.47, 95%CI: 1.88∼6.42, P<0.001) and further metastasis (Per2:OR=2.35, 95%CI: 1.35∼4.11, Ρ=0.003). Furthermore, the results revealed that low expressions of Per1 and Per2 were also correlated with poor overall survival of cancers (Per1: HR=1.35, 95%CI: 1.06∼1.72, P=0.014; Per2: HR=1.43, 95%CI: 1.10∼1.85, P=0.007). Subgroup analysis indicated that low Per1 and Per2 expressions were especially associated with poor prognosis of gastrointestinal caners (Per1: HR=1.33, 95%CI: 1.14∼1.55, Ρ<0.001, Ι(2)=4.2%; Per2: HR=1.62, 95%CI: 1.25∼2.18, P<0.001, I(2)=0.0%). CONCLUSIONS: Our study suggested that low Per1, Per2 and Npas2 expression played a distinct and crucial role in progression of cancers. Low expressions of Per1 and Per2 could serve as unfavorable indicators for cancers prognosis, especially for gastrointestinal cancers. |
format | Online Article Text |
id | pubmed-7241715 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-72417152020-06-08 Low circadian clock genes expression in cancers: A meta-analysis of its association with clinicopathological features and prognosis Zhang, Jiangguo Lv, Hong Ji, Mingzhu Wang, Zhimo Wu, Wenqing PLoS One Research Article BACKGROUND: Per1, Per2, Per3, Cry1, Cry2, Bmal1, Npas2 and CLOCK genes are the eight core circadian clock genes. Low expression of these circadian clock genes plays an important role in the progression of cancers. However, its clinicopathological and prognostic value in patients with cancers remains controversial and inconclusive. We performed a meta-analysis of studies assessing the clinicopathological and prognostic significance of low expression of these genes in cancers. METHODS: Relevant studies were searched from the Cochrane Central Register of Controlled Trials, Embase, EBSCO, Ovid, PubMed, Science Direct, Wiley Online Library database, CNKI and Wan Fang database. The meta-analysis was performed by using STATA version 12 software. A random-effect model was employed to evaluate all pooled hazard ratios (HRs) and odd ratios (ORs). RESULTS: A total of 36 studies comprising 7476 cases met the inclusion criteria. Meta-analysis suggested that low expression of Per1 was associated with poor differentiation (Per1: OR=2.30, 95%CI: 1.36∼3.87, P=0.002) and deeper invasion depth (Per1: OR=2.12, 95%CI: 1.62∼2.77, Ρ<0.001); low Per2 expression was correlated with poor differentiation (Per2: OR=2.41, 95%CI: 1.53∼3.79, Ρ<0.001), worse TNM stage (Per2:OR=3.47, 95%CI: 1.88∼6.42, P<0.001) and further metastasis (Per2:OR=2.35, 95%CI: 1.35∼4.11, Ρ=0.003). Furthermore, the results revealed that low expressions of Per1 and Per2 were also correlated with poor overall survival of cancers (Per1: HR=1.35, 95%CI: 1.06∼1.72, P=0.014; Per2: HR=1.43, 95%CI: 1.10∼1.85, P=0.007). Subgroup analysis indicated that low Per1 and Per2 expressions were especially associated with poor prognosis of gastrointestinal caners (Per1: HR=1.33, 95%CI: 1.14∼1.55, Ρ<0.001, Ι(2)=4.2%; Per2: HR=1.62, 95%CI: 1.25∼2.18, P<0.001, I(2)=0.0%). CONCLUSIONS: Our study suggested that low Per1, Per2 and Npas2 expression played a distinct and crucial role in progression of cancers. Low expressions of Per1 and Per2 could serve as unfavorable indicators for cancers prognosis, especially for gastrointestinal cancers. Public Library of Science 2020-05-21 /pmc/articles/PMC7241715/ /pubmed/32437452 http://dx.doi.org/10.1371/journal.pone.0233508 Text en © 2020 Zhang et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Zhang, Jiangguo Lv, Hong Ji, Mingzhu Wang, Zhimo Wu, Wenqing Low circadian clock genes expression in cancers: A meta-analysis of its association with clinicopathological features and prognosis |
title | Low circadian clock genes expression in cancers: A meta-analysis of its association with clinicopathological features and prognosis |
title_full | Low circadian clock genes expression in cancers: A meta-analysis of its association with clinicopathological features and prognosis |
title_fullStr | Low circadian clock genes expression in cancers: A meta-analysis of its association with clinicopathological features and prognosis |
title_full_unstemmed | Low circadian clock genes expression in cancers: A meta-analysis of its association with clinicopathological features and prognosis |
title_short | Low circadian clock genes expression in cancers: A meta-analysis of its association with clinicopathological features and prognosis |
title_sort | low circadian clock genes expression in cancers: a meta-analysis of its association with clinicopathological features and prognosis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241715/ https://www.ncbi.nlm.nih.gov/pubmed/32437452 http://dx.doi.org/10.1371/journal.pone.0233508 |
work_keys_str_mv | AT zhangjiangguo lowcircadianclockgenesexpressionincancersametaanalysisofitsassociationwithclinicopathologicalfeaturesandprognosis AT lvhong lowcircadianclockgenesexpressionincancersametaanalysisofitsassociationwithclinicopathologicalfeaturesandprognosis AT jimingzhu lowcircadianclockgenesexpressionincancersametaanalysisofitsassociationwithclinicopathologicalfeaturesandprognosis AT wangzhimo lowcircadianclockgenesexpressionincancersametaanalysisofitsassociationwithclinicopathologicalfeaturesandprognosis AT wuwenqing lowcircadianclockgenesexpressionincancersametaanalysisofitsassociationwithclinicopathologicalfeaturesandprognosis |